{
    "clinical_study": {
        "@rank": "164680", 
        "arm_group": [
            {
                "arm_group_label": "Ferric Citrate", 
                "arm_group_type": "Experimental", 
                "description": "Ferric citrate will be taken with or within one hour of meals or snacks.  The dose of ferric citrate will depend on the patient's serum phosphorus results at each treatment visit."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo will be taken with or within one hour of meals or snacks. The number of placebo pills will depend on the patient's serum phosphorus results at each treatment visit."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if KRX-0502 (ferric citrate) is a safe and\n      effective treatment for the management of serum phosphorus levels and iron deficiency in\n      anemic chronic kidney disease (CKD) subjects not on dialysis.  Total length of treatment is\n      approximately 12 weeks."
        }, 
        "brief_title": "Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Iron Deficiency", 
            "Iron Deficiency Anemia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anemia", 
                "Kidney Diseases", 
                "Deficiency Diseases", 
                "Anemia, Iron-Deficiency", 
                "Renal Insufficiency, Chronic", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a randomized, double-blind, placebo-controlled, three-period, multi-center clinical\n      trial. Following a Screening and Qualification Period and a two-week Washout Period (for\n      those subjects entering the study on a phosphate binder), eligible subjects will be\n      randomized in a 1:1 ratio to receive either KRX-0502 (ferric citrate) or placebo for up to\n      approximately 12 weeks. The purpose of this study is to determine if KRX-0502 (ferric\n      citrate) is a safe and effective treatment for the management of serum phosphorus levels and\n      iron deficiency in anemic CKD subjects not on dialysis."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Stage III to V Chronic Kidney Disease\n\n          -  Serum Phosphorus 4.0-6.0 mg/dL prior to Randomization\n\n          -  Ferritin 300 ng/mL or less\n\n          -  TSAT 30% or less\n\n          -  Hemoglobin >9.0 and <12.0 g/dL\n\n          -  Must consume a minimum of 2 meals per day\n\n        Exclusion Criteria:\n\n          -  Parathyroidectomy within 24 weeks of study\n\n          -  GI bleed or inflammatory bowel disease within 12 weeks of study\n\n          -  Requirement for dialysis or kidney injury within 8 weeks of study\n\n          -  Absolute requirement for oral iron, IV iron, Erythropoiesis-Stimulating Agent, blood\n             transfusions, and Sensipar during the study\n\n          -  Absolute requirement for calcium-, magnesium-, or aluminum-containing drugs with\n             meals\n\n          -  Absolute requirement for vitamin C, niacin, or nicotinamide outside of multivitamins\n\n          -  History of hemochromatosis\n\n          -  Allergy to iron products\n\n          -  History of malignancy in last 5 years"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "149", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 16, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01736397", 
            "org_study_id": "KRX-0502-204"
        }, 
        "intervention": {
            "arm_group_label": "Ferric Citrate", 
            "description": "Dose depends on serum phosphorus levels collected at each study visit.", 
            "intervention_name": "Ferric Citrate", 
            "intervention_type": "Drug", 
            "other_name": [
                "KRX-0502", 
                "Zerenex"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": "Citric Acid"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "CKD", 
            "Chronic Kidney Disease", 
            "Phosphorus", 
            "Iron Deficiency", 
            "Iron Deficiency Anemia", 
            "Elevated Phosphorus"
        ], 
        "lastchanged_date": "December 27, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Tempe", 
                        "country": "United States", 
                        "state": "Arizona"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Mesa", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edgewater", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Meridian", 
                        "country": "United States", 
                        "state": "Idaho"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Evergreen Park", 
                        "country": "United States", 
                        "state": "Illinois"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bethesda", 
                        "country": "United States", 
                        "state": "Maryland"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pontiac", 
                        "country": "United States", 
                        "state": "Michigan"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Reno", 
                        "country": "United States", 
                        "state": "Nevada"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Great Neck", 
                        "country": "United States", 
                        "state": "New York"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mineola", 
                        "country": "United States", 
                        "state": "New York"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Asheville", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wilmington", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orangeburg", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis", 
        "overall_official": [
            {
                "last_name": "Geoffrey Block, MD", 
                "role": "Study Chair"
            }, 
            {
                "last_name": "Glenn Chertow, MD", 
                "role": "Study Chair"
            }, 
            {
                "last_name": "Steven Fishbane, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Change in TSAT (transferrin saturation) from baseline to end of treatment", 
                "safety_issue": "No", 
                "time_frame": "12 Weeks"
            }, 
            {
                "measure": "Change in serum phosphorus levels from baseline to end of treatment", 
                "safety_issue": "No", 
                "time_frame": "12 Weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01736397"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "SAEs will be monitored for an additional 28 days after last study visit.", 
                "measure": "Rates of adverse events overall and by organ system class, preferred term, severity, and suspected relationship to study drug by treatment assignment as a measure of safety and tolerability", 
                "safety_issue": "Yes", 
                "time_frame": "Approximately 16 weeks"
            }, 
            {
                "measure": "Type of concomitant medications used by treatment assignment as a measure of safety", 
                "safety_issue": "Yes", 
                "time_frame": "Approximately 16 weeks"
            }, 
            {
                "measure": "Change in sequential blood chemistries by treatment assignment as a measure of safety", 
                "safety_issue": "Yes", 
                "time_frame": "12 Weeks"
            }, 
            {
                "measure": "Change in hemoglobin levels from baseline to end of treatment by treatment assignment as a measure of safety", 
                "safety_issue": "No", 
                "time_frame": "12 Weeks"
            }, 
            {
                "measure": "Change in ferritin levels from baseline to end of treatment", 
                "safety_issue": "No", 
                "time_frame": "12 Weeks"
            }
        ], 
        "source": "Keryx Biopharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Keryx Biopharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}